Welcome to our dedicated page for Accelerant Holdings SEC filings (Ticker: ARX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accelerant Holdings (NYSE: ARX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Accelerant is incorporated in the Cayman Islands and its Class A common shares are registered under Section 12(b) of the Exchange Act, trading on the New York Stock Exchange under the symbol ARX.
As a public company and emerging growth company, Accelerant files current reports on Form 8-K to announce material events, including the release of quarterly earnings results and the availability of earnings presentations. These 8-K filings often include or reference press releases that detail Exchange Written Premium, total revenues, net income or loss, Adjusted EBITDA, Adjusted Net Income and other key performance metrics for the specialty insurance risk exchange platform.
Investors can also use this page to locate periodic reports such as Forms 10-Q and 10-K once filed, which are expected to provide more extensive information on Accelerant’s financial statements, risk factors, business description and management’s discussion and analysis. The company has indicated that it files its Form 10-Q within the timelines applicable to a non-accelerated filer and emerging growth company.
In addition, the filings page is a resource for tracking capital markets and corporate structure disclosures, including the registration statement on Form S-1 that supported Accelerant’s initial public offering and the listing of its Class A common shares on the NYSE. Over time, users can review how Accelerant reports on its fee-based revenue model, the composition of Exchange Written Premium, the use of non-GAAP financial measures and items such as profit interest distribution expenses, share-based compensation and foreign currency effects.
Stock Titan enhances these documents with AI-powered summaries that highlight the main points of lengthy filings, helping readers quickly understand the significance of each report while still allowing full access to the underlying SEC documents for detailed review.
Accelerant Holdings (ARX) filed a Form 4 indicating that Co-Founder, Director and Head of Distribution Christopher Lee-Smith received a new stock-option grant on 23 Jul 2025. The option allows him to purchase 2,746,261 Class A common shares at an exercise price of $21 and was reported on 25 Jul 2025.
Vesting terms are service-based: 25 % vests on 23 Jul 2026 (one-year cliff) and the remaining 75 % vests in 6.25 % quarterly installments through 23 Jul 2029. The option expires on 23 Jul 2035. After the transaction, Lee-Smith beneficially owns 2,746,261 derivative securities; no non-derivative share movement was disclosed.
The award strengthens management alignment over a four-year horizon, yet represents potential future dilution of roughly 2.75 million shares should the options be exercised.
On 07/23/2025, Accelerant Holdings (ARX) filed a Form 4 disclosing an initial grant of 209,515 stock options to newly appointed director Wendy Liisa Harrington.
- Exercise price: $21 per Class A common share.
- Vesting: 25 % cliff on 07/23/2026, then 6.25 % quarterly through 07/23/2029 (full vesting in four years), contingent on continuous service.
- Expiration: 07/23/2035 (10-year term).
- Post-transaction beneficial ownership: 209,515 derivative securities; no non-derivative share changes were reported.
The filing reflects a routine equity-compensation award meant to align director incentives with shareholder value. While the award represents potential future dilution, it is immaterial relative to ARX’s presumed outstanding share base and involves no cash outlay by the company today. No earnings data or other material corporate events were disclosed in this filing.